Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Clark

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Vaccine|December 22, 2019
Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosisFlorence Levillain, Hongmin Kim, Kee Woong Kwon, et al.
Scientific Reports|October 2, 2020
Author Correction: Development of a diagnostic compatible BCG vaccine against Bovine tuberculosisAneesh Chandran, Kerstin Williams, Tom Mendum, et al.
Scientific Reports|November 30, 2019
Development of a diagnostic compatible BCG vaccine against Bovine tuberculosisAneesh Chandran, Kerstin Williams, Tom Mendum, et al.
Vaccine|February 7, 2015
Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosisPeter Sander, Simon Clark, Agnese Petrera, et al.
Vaccine|August 23, 2013
Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trialsAinhoa Arbues, Juan I Aguilo, Jesus Gonzalo-Asensio, et al.
Clinical Radiology|December 23, 2022
Alerts and notification of imaging reports recommendationsTeik Choon See, , Mark Callaway, et al.
The Lancet. Rheumatology|May 10, 2021
Surgical microdiscectomy versus transforaminal epidural steroid injection in patients with sciatica secondary to herniated lumbar disc (NERVES): a phase 3, multicentre, open-label, randomised controlled trial and economic evaluationMartin John Wilby, Ashley Best, Eifiona Wood, et al.
NPJ Vaccines|January 5, 2021
MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studiesAndrew D White, Laura Sibley, Charlotte Sarfas, et al.
Infection and Immunity|October 9, 2019
Construction and Characterization of the Mycobacterium tuberculosis <i>sigE fadD26</i> Unmarked Double Mutant as a Vaccine CandidateRogelio Hernandez-Pando, Sung Jae Shin, Simon Clark, et al.
Scientific Reports|June 11, 2021
High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluationLaura Sibley, Andrew D White, Karen E Gooch, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Vaccine|December 22, 2019
Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosisFlorence Levillain, Hongmin Kim, Kee Woong Kwon, et al.
Scientific Reports|October 2, 2020
Author Correction: Development of a diagnostic compatible BCG vaccine against Bovine tuberculosisAneesh Chandran, Kerstin Williams, Tom Mendum, et al.
Scientific Reports|November 30, 2019
Development of a diagnostic compatible BCG vaccine against Bovine tuberculosisAneesh Chandran, Kerstin Williams, Tom Mendum, et al.
Vaccine|February 7, 2015
Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosisPeter Sander, Simon Clark, Agnese Petrera, et al.
Vaccine|August 23, 2013
Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trialsAinhoa Arbues, Juan I Aguilo, Jesus Gonzalo-Asensio, et al.
Clinical Radiology|December 23, 2022
Alerts and notification of imaging reports recommendationsTeik Choon See, , Mark Callaway, et al.
The Lancet. Rheumatology|May 10, 2021
Surgical microdiscectomy versus transforaminal epidural steroid injection in patients with sciatica secondary to herniated lumbar disc (NERVES): a phase 3, multicentre, open-label, randomised controlled trial and economic evaluationMartin John Wilby, Ashley Best, Eifiona Wood, et al.
NPJ Vaccines|January 5, 2021
MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studiesAndrew D White, Laura Sibley, Charlotte Sarfas, et al.
Infection and Immunity|October 9, 2019
Construction and Characterization of the Mycobacterium tuberculosis <i>sigE fadD26</i> Unmarked Double Mutant as a Vaccine CandidateRogelio Hernandez-Pando, Sung Jae Shin, Simon Clark, et al.
Scientific Reports|June 11, 2021
High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluationLaura Sibley, Andrew D White, Karen E Gooch, et al.
Pageof 10